International panel offers new ways to define obesity
Using body-mass index to tell who is overweight or obese is not reliable and can result in misdiagnosis, the Commission on ...
FDA proposes warning label on front of food packaging to combat obesity epidemic
The FDA has designed five different types of labels, each presenting the same information but with different specifications based on the size of the packaging.
Say Bye to Just BMI: Experts Call for a Major Shift in How We Measure Obesity
An international and widely supported group of experts is pushing doctors to avoid the exclusive use of BMI to decide whether ...
STAT3d
Beyond BMI: New report reframes obesity as a spectrum of illness, not just a risk factor
BMI has long been falling out of favor. When the American Medical Association urged downgrading BMI in 2023, it blamed its ...
STAT3d
Demoting BMI, a new food label from the FDA, and risks of even moderate drinking
An international group of experts proposes two new categories of disease: preclinical and clinical obesity and the FDA ...
Zawya5d
FDA approves Tirzepatideas: The first and only prescription medicine for moderate-to-severe obstructive sleep apnea in adults with obesity
Averaging up to 20% of weight loss, adults taking Tirzepatide had at least 25 fewer breathing interruptions each hour as they ...
Pharmaceutical Technology2d
Designing clinical trials for a complex disease: pediatric obesity
Treating the growing problem of childhood obesity calls for exploring new approaches and treatments through well-designed ...
Washington Examiner4d
FDA proposes warning label on front of food packaging to combat obesity epidemic
Sen. Bernie Sanders (I-VT) proposed in February 2024 that the FDA place warning labels about the risk of developing Type 2 diabetes or obesity on foods with high saturated fat, added sugar ...
Lilly oral obesity drug could get FDA okay in early 2026: report
CEO Dave Ricks said Monday that the company's weight-loss pill orforglipron could receive FDA approval as soon as early 2026. Read more here.
24/7 Wall St1d
Novo Nordisk A/S (NVO) Price Prediction and Forecast 2025-2030
When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...
TCTMD3d
Global Commission Proposes ‘Radical’ Overhaul of Obesity Diagnosis
The two-tiered classification focuses on preclinical and clinical stages of disease, and should help inform treatment ...
Seeking Alpha5d
Lilly oral obesity drug could get FDA okay in early 2026: report
Eli Lilly (NYSE:LLY) CEO Dave Ricks said Monday that the company's GLP-1 weight-loss pill orforglipron could receive FDA approval as soon as early 2026. In an interview with Bloomberg TV ...